Live tape
Top 8, mentions 7d14,225TSLA3,256 mentions▲ +0.05SPCX2,703 mentions▲ +0.08GOOGL1,914 mentions▲ +0.03META1,882 mentions▲ +0.05QQQ1,209 mentions▲ +0.04NVDA1,141 mentions▲ +0.07CRWV1,072 mentions▲ +0.04NFLX1,048 mentions▲ +0.03

Equity · Healthcare

PGNY

NASDAQ

Progyny (PGNY)

$32 +0.47% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for PGNY to draw a line in its place.

Market cap $2.5B
P/E (TTM) 34.8
52-week range $16.29 – $32.32
Avg volume 280.1K

as of Jul 17, 2026

Progyny (PGNY) insider trades

SEC Form 4 · last 90 days · newest reported trade 14 Oct 2026

In the 90 days to 23 Oct 2026, Progyny insiders reported 3 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 13 Nov 2025.

Open-market buys 0
Open-market sells 3
Net sold $788K
Non-trade filings 11
Date Insider Type Shares Value
14 Oct 2026 Cummings Melissa B Chief Operating Officer Sell 1,879 $53K
23 Sep 2026 Swartz Allison EVP, GC Sell 3,903 $102K
10 Sep 2026 GORDON KEVIN K Director Sell 23,000 $633K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
14 Oct 2026 Cummings Melissa B Chief Operating Officer Tax withheld 1,559 $43K
17 Sep 2026 Clapp Geoffrey Chief Product Officer Tax withheld 819 $22K
10 Sep 2026 GORDON KEVIN K Director Option exercise 22,000 $286K
10 Sep 2026 GORDON KEVIN K Director Tax withheld 10,500 $286K
04 Sep 2026 Livingston Mark S. CHIEF FINANCIAL OFFICER Tax withheld 479 $13K
04 Sep 2026 Swartz Allison EVP, GC Tax withheld 479 $13K
03 Sep 2026 Livingston Mark S. CHIEF FINANCIAL OFFICER Tax withheld 1,532 $40K
03 Sep 2026 Anevski Peter CHIEF EXECUTIVE OFFICER Tax withheld 5,361 $141K
03 Sep 2026 Swartz Allison EVP, GC Tax withheld 828 $22K
02 Sep 2026 Livingston Mark S. CHIEF FINANCIAL OFFICER Tax withheld 224 $6K
28 Aug 2026 Swartz Allison EVP, GC Tax withheld 1,352 $35K

Progyny (PGNY) reported financials

SEC EDGAR XBRL SEC EDGAR

Progyny reported revenue of $1.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was $58.5M.

Figure Reported Period
Revenue $1.3B 31 Dec 2025 fiscal year
Net income $58.5M 31 Dec 2025 fiscal year
Diluted EPS $0.65 31 Dec 2025 fiscal year
Total assets $715.8M 30 Jun 2026 at period end
Total equity $453.3M 30 Jun 2026 at period end

Progyny (PGNY) earnings

SEC EDGAR

Progyny last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.34; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.34 $351M
31 Mar 2026 Q1 2026 $0.29 $329M
31 Dec 2025 FY 2025 $0.14 $318M
30 Sep 2025 FY 2025 $0.15 $313M
30 Jun 2025 FY 2025 $0.19 $333M
31 Mar 2025 Q1 2025 $0.17 $324M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Progyny (PGNY) institutional holders (13F)

SEC Form 13F SEC EDGAR

10 of the 45 institutional funds we track reported a Progyny position for the quarter ended 30 Jun 2026 — a combined $115.7M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Citadel Advisors New position 1,785,717 $51.5M
AQR Capital Management Held (±25%) +21.5% shares 797,534 $23.0M
Millennium Management Added +488.6% shares 439,622 $12.7M
Renaissance Technologies Trimmed −47.7% shares 424,667 $12.2M
Marshall Wace Trimmed −27.8% shares 344,127 $9.9M
Balyasny Asset Management Trimmed −75.3% shares 103,212 $3.0M
Bridgewater Associates New position 51,738 $1.5M
Man Group Trimmed −88.9% shares 35,357 $1.0M
D. E. Shaw & Co. Trimmed −84.7% shares 18,239 $526K
Two Sigma Investments Trimmed −49.1% shares 13,000 $375K

Progyny (PGNY) fails-to-deliver

SEC CNS data SEC

On 28 Sep 2026, 670 shares of Progyny failed to deliver (about $17K).

Settlement date Shares failed Notional % of shares out
28 Sep 2026 670 $17K 0.001%

Congressional trades in Progyny (PGNY)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Progyny is a sale by Josh Gottheimer (house, NJ), dated 06 Dec 2024.

Date Member Type Amount
06 Dec 2024 filed 14 Jan 2025 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
30 Jul 2020 filed 19 Aug 2020 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
30 Jun 2020 filed 17 Jul 2020 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
01 Jun 2020 filed 16 Jun 2020 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K

Progyny (PGNY): frequently asked questions

From live data

Have Progyny insiders bought or sold shares recently?

In the 90 days to 23 Oct 2026, Progyny insiders reported 3 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 13 Nov 2025. A further 11 filings were grants, awards, gifts or exercises rather than open-market trades.

How many institutions hold Progyny?

10 of the 45 institutional funds we track reported a Progyny position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Progyny had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Progyny is dated 28 Sep 2026, when 670 shares failed to deliver.

When did Progyny last report earnings?

Progyny last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.34; no next date is announced in SEC filings yet.

What exchange is Progyny listed on?

Progyny trades on NASDAQ under the ticker PGNY.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings